GPT and metabolic dysfunction-associated steatotic liver disease: In pediatric populations, genetic variants in PNPLA3 and TM6SF2 have been consistently associated with increased hepatic fat accumulation, elevated alanine aminotransferase (ALT) levels, and greater histological severity of MASLD, with additive effects observed when risk alleles co-occur [13,14].